Real-time cancer diagnostics and therapy through theranostics
Development of more precise, personalized treatments with fewer side effects, assisted by artificial intelligence. This is the focus of “Thera4Care,” a European project coordinated by experts from Università Cattolica and Fondazione Policlinico Unive
2024-10-07
(Press-News.org)
Developing new cancer treatment tools, using imaging techniques such as PET-CT and MRI, and new radiopharmaceuticals for next-generation personalized therapies (“Theranostics”) to target cancer first at the “diagnosis” phase and then at the “therapy” phase, using the same biological targets (“see to treat”). Additionally, the project aims to develop and implement AI-based tools for data sharing among research and hospitals, supporting clinical decisions and predicting individual patient treatment response and outcome.
This is the main focus of the Horizon IHI Project, “Thera4Care - Theranostics Ecosystem for Personalised Care,” the largest European project on Theranostics, coordinated by Università Cattolica, Rome, and Fondazione Policlinico Universitario Agostino Gemelli IRCCS. To launch Thera4Care, Università Cattolica will host the Kick-Off Meeting on October 7-8, 2024, at the campus (Room 201, Faculty of Economics) and Policlinico Universitario A. Gemelli IRCCS (Room 716, 7th floor).
The focus of the kick-off meeting will be to align the team on the project’s objectives and expectations. Additionally, the meeting will review the project’s timeline and resources, discuss potential risks, and management strategies of the various research groups involved. This meeting will ensure that all participants are informed and prepared to start the project, which is funded by the European Commission under the Innovative Health Initiative (IHI, Horizon Europe), with a total funding of approximately €28 million, supporting a consortium of 29 international partners from academia and industry.
The entire project and European consortium will be coordinated by Evis Sala, Professor of Diagnostic Imaging and Radiotherapy at Università Cattolica and Director of the Department of Diagnostic Imaging and Radiotherapy at Fondazione Gemelli IRCCS, and Dr. Salvatore Annunziata, a Nuclear Medicine physician and the Head of the GSTeP Radiopharmacy Facility at Fondazione Policlinico Universitario Agostino Gemelli IRCCS, supported by a team of project and grant managers (Saverio Gravina, Rachele Brancaleoni, Laura Motta), and the Scientific Directorate and GSTeP Facilities of Fondazione Policlinico Universitario A. Gemelli IRCCS.
The kick-off meeting will host approximately 70 participants from various European and non-European countries, representing the 29 academic and industrial partners, to introduce and plan the project activities, which will develop into 9 work packages over the next 5 years.
The project aims to create a European network of excellence, capable of revolutionizing and surpassing current theranostic procedures with conventional radiopharmaceuticals (such as PSMA for prostate cancer or DOTATOC for neuroendocrine tumors) by developing new theranostic radiopharmaceuticals with next-generation ligands and radioisotopes (like FAPI for the tumor microenvironment and short-range alpha-emitting radioisotopes). The focus is on female and gastrointestinal tumours, with the goal of reducing exposure to healthy tissues and healthcare personnel, integrating theranostics into a multimodal context with MRI and AI (to enhance treatment selection and evaluation), improving diagnostic technologies supporting theranostics (PET, SPECT, dosimetry), and finally, establishing and promoting a new European School of Theranostics in collaboration with scientific and patient associations.
Professor Sala and Dr. Annunziata stated: “Università Cattolica and Fondazione Gemelli IRCCS will coordinate the entire project and, together with the Scientific Directorate and other Departments of Fondazione Policlinico Universitario A. Gemelli IRCCS, will implement new radiopharmaceutical therapies for gynecological and gastrointestinal cancers, MRI applications, and artificial intelligence, and train on theranostics at a European level.”
Professor Antonio Gasbarrini, Dean of the Faculty of Medicine and Surgery at Università Cattolica said: “We are deeply proud to lead this innovative European project on theranostics, a frontier where diagnostics and therapy merge to offer increasingly personalized and effective treatments. Our goal is to provide the international scientific community with cutting-edge expertise to improve patient care prospects. Coordinating this initiative means promoting collaboration between research and clinical practice, creating synergies that can revolutionize the approach to complex diseases. Our University thus reaffirms its commitment to being a center of excellence and innovation in the medical field.”
Prof. Giovanni Scambia, Scientific Director of the IRCCS Fondazione Policlinico Universitario Agostino Gemelli, explained: “this project is very important for Policlinico Gemelli, which aims to position itself as a reference hospital for Precision Medicine. In this context, the launch of a Theranostics project becomes an essential aid for oncology patients at the Policlinico, contributing significantly to personalized care and initiating important research projects,” he concluded.
END
ELSE PRESS RELEASES FROM THIS DATE:
2024-10-07
Vaccines to prevent common and serious infectious diseases have had a greater impact on improving human health than any other medical advance of the 20th century, surpassing even sanitation and potable water. From the global eradication of smallpox in 1980 to the unprecedented development of effective and safe mRNA vaccines for COVID-19, vaccinations have played crucial roles in preventing millions of premature deaths and hospitalizations in adults and children.
These monumental efforts have involved coordinated local, regional, national and international organizations and dedicated clinical ...
2024-10-07
With hundreds of observatories scattered throughout the world, there has never been a better time for astronomers to observe the infinite universe that lies beyond Earth. At any moment in time, a telescope pointed at the night sky can observe new transient phenomena, such as supernovae that brighten rapidly and then fade away over days to months, releasing massive amounts of energy in the process. These events are rare in any single galaxy and each gives researchers more insight into the dynamic time-domain sky.
But what if these observatories could work even closer together to view these important astronomical events?
The National ...
2024-10-07
A research team from the International Research Institute for Artificial Intelligence at Harbin Institute of Technology, Shenzhen, has recently published a comprehensive review in the journal Health Data Science on the application of Brain Network Models (BNMs) in the medical field. This study summarizes recent advances and challenges in using BNMs to simulate brain activities, understand neuropathological mechanisms, evaluate therapeutic effects, and predict disease progression.
Brain Network Models ...
2024-10-07
NEWPORT NEWS, VA – Four physicists affiliated with the U.S. Department of Energy’s Thomas Jefferson National Accelerator Facility have been selected by their peers for the distinct honor of Fellow of the American Physical Society.
“Our staff power the science and innovation that are continuing to move the discipline of physics and this laboratory into the future,” said Jefferson Lab Director Kim Sawyer. “We’re very proud that the accomplishments and contributions of these four Jefferson Lab staff members to the field of physics are being recognized by their peers with this honor.”
According to the APS, fellows have made ...
2024-10-07
COLUMBUS, Ohio – Psychiatric drugs are reported to be about 50% more effective in clinical trials funded by the drug’s manufacturer than when trials of the same drug are sponsored by other groups, new research shows.
While many studies have found more favorable results for drugs in clinical trials funded by their manufacturers, these studies normally just compare a set of manufacturer-funded studies with a set of studies funded in other ways, said Tamar Oostrom, assistant professor of economics at The Ohio State University, who conducted this new research.
This ...
2024-10-07
UTSA was selected by the U.S. Department of Energy’s (DOE) Office of Nuclear Energy (NE) to lead a multimillion-dollar project that will stimulate nuclear energy research at UTSA, leverage novel experimental data to bolster computational efforts at the university, and provide professional training to prepare undergraduate and graduate students for careers in nuclear energy science. UTSA researchers will collaborate with a leading nuclear energy laboratory as well as across academic institutions.
The award is part of the DOE’s Nuclear Energy University Program’s Integrated Research Projects (IRPs). These projects aim to provide research and development solutions ...
2024-10-07
The accumulation of fats in the liver is driven by high-fat diets and obesity, and is becoming an increasingly prevalent global health concern. Characterized by excessive fat accumulation in the liver, this condition poses significant risks for various metabolic disorders. While much of the existing research has focused on fat metabolism within the liver itself, emerging findings emphasize the critical role of the gut in this complex process. Proglucagon-derived peptides (PGDPs), including glucagon, GLP-1, and GLP-2, are known to be the key hormones that regulate lipid metabolism in the liver. Derived from the same precursor—proglucagon, previous studies ...
2024-10-07
The surge in the adoption of renewable energy, coupled with the rapid growth of the electric vehicle market in recent years has significantly increased the demand for high-performance, all-solid-state batteries. Compared to conventional liquid electrolyte-based batteries, solid-state batteries offer higher energy density, improved safety, longer lifespan, and reliable operation over a wide temperature range. However, there are still challenges to their widespread applications, including low ionic conductivity, high interfacial resistance, and the presence of particle-particle interfaces in the electrolyte, which leads to increased resistance and lower energy density.
Notably, ...
2024-10-07
The human microbiome plays a critical role in our health, influencing everything from disease development to treatment responses. This connection has captured the attention of scientists worldwide, eager to unlock its secrets. While traditional metagenomics has provided valuable insights, it falls short in resolving microbial diversity at the strain level and accurately profiling genes involved in antibiotic resistance. These limitations highlight the need for more advanced approaches.
To address this, a team of researchers led by Associate Professor Masahito Hosokawa, from Waseda University, in collaboration with bitBiome, Inc., developed a groundbreaking single-cell ...
2024-10-07
The winner of one of the UK’s biggest academic prizes has discovered what he believes is the key to long-term innovation and economic growth: unplanned intellectual friendships – like Greek philosophers Plato and Aristotle, or DNA pioneers James Watson and Francis Crick.
Professor Kirk Doran, an Associate Professor of Economics at the University of Notre Dame in Indiana in the United States, has been researching what drives innovation for 14 years – and has made his discovery by forensically analysing data including published research and census, tax, migration and historical data.
Professor Doran has ...
LAST 30 PRESS RELEASES:
[Press-News.org] Real-time cancer diagnostics and therapy through theranostics
Development of more precise, personalized treatments with fewer side effects, assisted by artificial intelligence. This is the focus of “Thera4Care,” a European project coordinated by experts from Università Cattolica and Fondazione Policlinico Unive
